The Sensitivity to Cytosine Arabinoside of the Blast Progenitors of Acute Myeloblastic Leukemia

Blood - United States
doi 10.1182/blood.v67.3.762.762
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Cytidine Deaminase Genotype and Toxicity of Cytosine Arabinoside Therapy in Children With Acute Myeloid Leukemia

British Journal of Haematology
Hematology
2009English

Post-Remission Therapy of Adult Acute Myeloid Leukemia: High Dose Cytosine-Arabinoside Versus Other Consolidation Regimens

Medicinski Pregled
Medicine
2014English

The First Symptom of Acute Myeloblastic Leukemia: Massive Epistaxis

European Journal of Rhinology and Allergy
2019English

Membrane Transport Influences the Rate of Accumulation of Cytosine Arabinoside in Human Leukemia Cells.

Journal of Clinical Investigation
Medicine
1987English

A Rare Case of Acute Myeloblastic Leukemia With Blast Count Less Than 20% in Bone Marrow

Case Reports in Clinical Practice
2019English

Cutaneous Mucormycosis Associated With Acute Myeloblastic Leukemia.

Japanese Journal of Medical Mycology
1989English

Effect of the Antiviral Drug, Cytosine Arabinoside, on the Developing Nervous System

Pediatric Research
Child HealthPediatricsPerinatology
1974English

Studies on the Optimal Dosage for Activation of Cytosine Arabinoside (Ara-C).

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1989English

Intensive Chemotherapy With Idarubicin, Cytosine Arabinoside, and Granulocyte Colony-Stimulating Factor (G-Csf) in Patients With Secondary and Therapy-Related Acute Myelogenous Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy